Caring for the Fragile elders: An Interdisciplinary Approach from Nutrition, Pain Management to Spiritual Care in Long Term Care Settings. Inaugurational Conference – 3 August 2024 – Taiwan

Prof. Yola Moride, President of YolaRX Consultants, will present on the “Use of Medical Cannabis in Elderly Patients Care: Current Challenges and Practical Recommendations” at Fu Jen Catholic University of Taipei. If you would like to learn more, contact us: contact@yolarx.com Read more

40th International Conference on Pharmacoepidemiology (ICPE)- Berlin 24-28 August 2024

Prof. Yola Moride, President of YolaRX Consultants, is a presenter of a poster on Systematic emulation trials to evaluate the real-world effectiveness of multiple sclerosis treatments.

Read more

DIA Canadian Annual Meeting – 18-19 October 2022 – Ottawa (Canada)

Prof. Moride, President and founder of YOLARX Consultants, presented at DIA Canada, “Key Considerations for Successful Risk Minimization” on 19 October 2022 (09:20–10:35 AM). If you would like to learn more, contact us: contact@yolarx.com.

Article “Impact of the COVID-19 Pandemic on Patterns of Prescription Opioid Use: A Retrospective Cohort Study of Adults Without a Cancer Diagnosis Initiating Opioids Using Administrative Claims Data” released in ‘Drugs – Real World Outcomes’ today

YOLARX Consultants is proud to announce the release of our researchers’ latest contribution to advance the understanding of the impact of the COVID-19 pandemic on the use of prescription opioids in Canada. Read more

21st Annual Meeting of the International Society of Pharmacovigilance (ISoP 2022) – Verona (Italy) – 20-23 September 2022

YOLARX attended ISoP’s 2022 Annual Meeting which took place from 20 to 23 September in Verona, Italy under the theme “A new Era of Pharmacovigilance: challenges and opportunities”.  Read more

38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) 2020, Copenhagen – Denmark, 24-28 August 2022

YOLARX participated at ICPE 2022 with 3 posters, 1 oral presentation, and 1 pre-conference course.   Read more

Article “Evaluation of interventions and policies on opioids in Canada: A mixed-methods descriptive study” released in ‘International Journal of Environmental Research and Public Health’ today

YOLARX Consultants is proud to announce the release of our researchers’ latest contribution to advance the understanding of “all components of the therapeutic risk minimization framework (i.e., intervention coverage, process indicators, health outcomes)” for opioids in Canada. Read more

DUPHAT – Dubai International Pharmaceuticals & Technologies Conference and Exhibition – 22-24 February 2022

Prof. Moride, president and founder of YOLARX Consultants, attended the 2022 DUPHAT, the biggest pharmaceutical event in the Middle East & Africa. She presented on the “Impact of the COVID-19 pandemic on risk management and risk minimization” as well as “New insights in therapeutic risk management, a focus on pharmacists’ role”.

20th Annual Meeting of the International Society of Pharmacovigilance (ISoP 2021) – Muscat (Oman) – 08-10 November 2021

Prof. Moride, president and founder of YolaRx Consultants, will speak about “Risk management and minimization” presented in the session on “Integrating safety data and knowledge from different information sources” which will take place on Monday, November 8th, 17:00 – 18:30, UTC.

We are hiring: Research Associate in Pharmacoepidemiology

You would like to integrate into a company that is constantly evolving, to join a young and dynamic team and to take on new challenges? Consult our job openings and submit your application to: contact@yolarx.com. Read more